In addition, Takagi et al. (2017) found that the LSD1 inhibitor T-3775440 inhibits the proliferation of lung cancer cells by disrupting the LSD1 interaction with the SNAG domain proteins INSM1 and GFI1B. The gene discussed is GFI1B; the disease is lung carcinoma.